- Home
- MBRX vs SEED Comparison
MBRX vs SEED Comparison
Compare MBRX & SEED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MBRX | SEED |
|---|---|---|
| Founded | 2015 | 1997 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7M | 12.3M |
| IPO Year | 2016 | 2005 |
Fundamental Metrics
Financial Performance| Metric | MBRX | SEED |
|---|---|---|
| Price | $0.67 | $1.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $61.00 | N/A |
| AVG Volume (30 Days) | ★ 872.6K | 64.0K |
| Earning Date | 05-12-2026 | 01-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.16 | $0.87 |
| 52 Week High | $7.98 | $2.49 |
Technical Indicators
Market Signals| Indicator | MBRX | SEED |
|---|---|---|
| Relative Strength Index (RSI) | 36.92 | 53.55 |
| Support Level | $0.26 | $0.96 |
| Resistance Level | $2.26 | $1.05 |
| Average True Range (ATR) | 0.07 | 0.03 |
| MACD | 0.08 | 0.00 |
| Stochastic Oscillator | 65.26 | 55.51 |
Price Performance
Historical ComparisonAbout MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.
About SEED Origin Agritech Limited
Origin Agritech Ltd is a Chinese agricultural technology company operating in the PRC including seed research and development activities featured in crop seed breeding and genetic improvement. The company's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits.